Frontlight ResearchEarly access
Trial site
D&H National Research Centers, Inc
- 5running trials
- 7closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)2 trials
- Gout2 trials
- Lupus (SLE)2 trials
- Type 2 diabetes2 trials
- Asthma1 trial
- Chronic kidney disease1 trial
- Insomnia1 trial
- Rheumatoid arthritis1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 37 trials
- Phase 23 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed4 trials
- Terminated3 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Viatris Innovation GmbH2 trials
- Amgen1 trial
- Apollo Therapeutics Ltd1 trial
- Eli Lilly and Company1 trial
- Idorsia Pharmaceuticals Ltd.1 trial
- and 6 more
Running trials
Recruiting
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Recruiting
Enrolling by invitation
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes2 recruiting
- Chronic kidney disease1 recruiting
- Lupus (SLE)1 recruiting
Closed trials
Completed
A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
Completed
Completed
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Terminated
Completed
Terminated
Terminated
Site data: ClinicalTrials.govUpdated 13 Nov 2026